Table 2 Descriptive statistics for the primary and secondary outcomes at baseline (T0), post-intervention (T3) and 3-month follow-up (T4). Values are given as mean differences (with standard deviations).
A-MR (n = 27) | MR (n = 28) | NT (n = 27) | |||||||
|---|---|---|---|---|---|---|---|---|---|
T0 | T3 | T4 | T0 | T3 | T4 | T0 | T3 | T4 | |
Mean (SD) * | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD)* | Mean (SD) | Mean (SD) | |
TRIG | 52.0 (5.91) | 34.1 (8.90) | 33.2 (9.18) | 53.2 (8.12) | 45.2 (9.59) | 43.2 (9.92) | 51.3 (6.90) | 47.7 (9.18) | 45.0 (10.20) |
TGI-SR | 64.2 (9.43) | 38.4 (8.86) | 35.9 (11.10) | 61.0 (10.78) | 47.5 (12.14) | 45.8 (14.62) | 56.3 (14.72) | 50.3 (12.95) | 47.2 (13.15) |
PSGI-SF | 23.1 (9.82) | 35.1 (9.62) | 37.0 (10.92) | 25.2 (10.82) | 28.0 (8.01) | 30.6 (11.05) | 27.1 (13.77) | 28.2 (10.96) | 27.9 (12.44) |
QoL-P. H | 16.4 (2.89) | 20.4 (3.09) | 20.5 (3.37) | 16.6 (3.34) | 18.3 (3.35) | 18.4 (3.54) | 17.8 (2.82) | 18.7 (2.22) | 18.6 (2.56) |
QoL-S. R | 7.52 (2.46) | 9.96 (2.93) | 10.37 (2.68) | 8.86 (2.49) | 10.0 (2.45) | 10.0 (2.74) | 9.70 (1.92) | 9.26 (9.26) | 9.70 (2.25) |